The largest database of trusted experimental protocols

The EBRG1 is a compact bench-top refrigerated centrifuge designed for general laboratory use. It provides reliable and consistent performance for a variety of centrifugation applications.

Automatically generated - may contain errors

4 protocols using ebrg1

1

IL-10 Modulation of C21 Effects in LPS-Induced Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were randomized into 7 groups (n = 6 each): i) Control (isotype), ii) C21, iii) LPS, iv) C21 + LPS, v) Neutralizing IL-10 antibody (IL-10Ab)+C21, vi) IL-10Ab + C21 + LPS vii) IL-10Ab + LPS. LPS (L2880, Sigma Aldrich) was given at a dose of 5 mg/kg. Rat IgG1 kappa isotype control (eBRG1, Thermo Fisher Scientific) and a neutralizing IL-10 monoclonal antibody (JES5-2A5, Thermo Fisher Scientific) were given a dose of 200 μg/mice in a total volume of 200 μL. IL-10 Ab treatment was given 1-h prior to C21, and LPS treatment was given 1-h after C21. Mice were euthanized 1-h post LPS.
+ Open protocol
+ Expand
2

SARS-CoV-2 Infection in Transgenic hACE2 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
8–16 week-old male Tg (K18-hACE2) 2Prlmn (Jackson Laboratories; ref. 20 (link)) mice were challenged with 5,000 PFU of SARS-CoV-2, Hong Kong/VM20001061/2020 (BEI Resources), in 50 μL by an i.n. route under 100 μL ketamine/xylazine sedation. Mice were followed daily for clinical symptoms, which included weight loss (scores 0–5), activity (scores 0–3), fur appearance and posture (scores 0–2), and eye closure (scores 0–2). Mice were given 150 μg of anti–IL-13 (Thermo Fisher Scientific, eBio1316H; catalog 16-7135-85) or an isotype matched control IgG (Thermo Fisher Scientific, eBRG1; catalog 16-4301-85) administered on day 0, 2, and 4 after infection. For experiments utilizing hyaluronidase, 14 U in 70 μL of ovine testicular hyaluronidase (Vitrase; 200 USP U/mL) or saline control were administered i.n. following isoflurane anesthetization on day 5 after infection. For anti-CD44 experiments, 100 μg of anti-CD44 (BD Biosciences, IM7; catalog 553131) or IgG2 (BD Biosciences, A95-1; catalog 559478) were administered on day 1 after infection, and then mice were given an additional 50 μg on days 2, 3, and 4.
+ Open protocol
+ Expand
3

Immune Response Analysis in Malaria Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was harvested 6 d post infection with P. berghei. Red blood cells were lysed with ACK and leukocytes were incubated with LPS (100 ng/μL) or vehicle plus GolgiPlug (BD) and monensin (eBioscience) for 4 h. Samples were blocked with anti-Fc receptor antibody (α-CD16/32, clone 2.4G2; UCSF Monoclonal Antibody Core) and labeled with antibodies to CD11b (M1/70) and F4/80 (BM8) (UCSF), Ly6c (HK1.4; eBioscience) and Ly6g (1A8; BioLegend). Following fixation and permeablization with Cytofix/Cytoperm (BD), intracellular labeling was performed with antibodies to IL-1β (NJTEN3), TNF (TN3-19), or rat IgG1 isotype (eBRG1) (all eBioscience). Samples were analyzed on an LSR II (BD). Classical monocytes were defined as CD11b+ Ly6g F4/80int Ly6chi, as previously described (13 (link)).
+ Open protocol
+ Expand
4

Subcutaneous Delivery of TNF-α Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the delivery of TNFα neutralizing antibodies (MP6-XT3, 1 mg·mL−1, Invitrogen) or the IgG1 kappa isotype control (eBRG1, 1 mg·mL−1, eBioscience), a total of 200 μL of the undiluted TNFα antibody or IgG was loaded into each Alzet minipump. The pumps were implanted subcutaneously into 6-week-old male TLR9−/− or WT mice, and the treatment continued for a total of 6 weeks.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!